TY - JOUR
T1 - Characteristics of preventive intervention acceptance for international travel among clients aged 60 years and older from a Japanese multicenter pretravel consultation registry
AU - Yamamoto, Kei
AU - Asai, Yusuke
AU - Nakagawa, Hidenori
AU - Nakatani, Issaku
AU - Hayashi, Kenichi
AU - Matono, Takashi
AU - Kanai, Shinichiro
AU - Yamato, Masaya
AU - Mikawa, Takahiro
AU - Shimatani, Michitsugu
AU - Shimono, Nobuyuki
AU - Shinohara, Koh
AU - Kitaura, Tsuyoshi
AU - Nagasaka, Atsushi
AU - Manabe, Akihiro
AU - Komiya, Nobuhiro
AU - Imakita, Natsuko
AU - Yamamoto, Yoshihiro
AU - Iwamoto, Noriko
AU - Okumura, Nobumasa
AU - Ohmagari, Norio
N1 - Publisher Copyright:
© 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control
PY - 2023/12
Y1 - 2023/12
N2 - Objectives: Pretravel consultation (PTC) is important for older adults owing to health problems associated with overseas travel. Although older adults in Japan, their PTC characteristics are less known. This study aimed to investigate the epidemiology of clients aged ≥ 60 years based on data from the Japan Pre-travel Consultation Registry (J-PRECOR). Methods: Clients aged ≥ 60 years who visited J-PRECOR cooperative hospitals from February 1, 2018, to May 31, 2022, were included. The primary endpoint was a comparison of prescriptions for vaccines for hepatitis A, tetanus toxoid, and malaria prophylaxis in travelers to high-risk malaria countries in yellow fever vaccination (YFV)-available facilities with and without YFV. Results: In total, 1000 clients (median age: 67 years) were included. Although 523 clients were immunized with YFV, only 38.6% of the 961 unimmunized clients were vaccinated with the tetanus toxoid-containing vaccine. Malaria chemoprophylaxis was prescribed to 25.7% of clients traveling for ≤55 days. At YFV-capable institutes, 557 clients traveling to yellow fever risk countries took PTC, 474 of whom received YFV and 83 were unvaccinated. Lower age (odds rate 0.85 per 1 year; 95% CI 0.80–0.90) and lower hepatitis A vaccination rate (0.29; 95% CI 0.14–0.63) were significantly associated with YFV. Conclusions: Preventive interventions other than YFV should be offered to older adults.
AB - Objectives: Pretravel consultation (PTC) is important for older adults owing to health problems associated with overseas travel. Although older adults in Japan, their PTC characteristics are less known. This study aimed to investigate the epidemiology of clients aged ≥ 60 years based on data from the Japan Pre-travel Consultation Registry (J-PRECOR). Methods: Clients aged ≥ 60 years who visited J-PRECOR cooperative hospitals from February 1, 2018, to May 31, 2022, were included. The primary endpoint was a comparison of prescriptions for vaccines for hepatitis A, tetanus toxoid, and malaria prophylaxis in travelers to high-risk malaria countries in yellow fever vaccination (YFV)-available facilities with and without YFV. Results: In total, 1000 clients (median age: 67 years) were included. Although 523 clients were immunized with YFV, only 38.6% of the 961 unimmunized clients were vaccinated with the tetanus toxoid-containing vaccine. Malaria chemoprophylaxis was prescribed to 25.7% of clients traveling for ≤55 days. At YFV-capable institutes, 557 clients traveling to yellow fever risk countries took PTC, 474 of whom received YFV and 83 were unvaccinated. Lower age (odds rate 0.85 per 1 year; 95% CI 0.80–0.90) and lower hepatitis A vaccination rate (0.29; 95% CI 0.14–0.63) were significantly associated with YFV. Conclusions: Preventive interventions other than YFV should be offered to older adults.
KW - International travel
KW - Japan
KW - Multicenter registry
KW - Older adults
KW - Pretravel consultation
KW - Travelers' vaccinations
UR - http://www.scopus.com/inward/record.url?scp=85168727097&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2023.08.013
DO - 10.1016/j.jiac.2023.08.013
M3 - 学術論文
C2 - 37598777
AN - SCOPUS:85168727097
SN - 1341-321X
VL - 29
SP - 1137
EP - 1144
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 12
ER -